Lifecore Biomedical, Inc. (LFCR) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 5 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for LFCR is $6.50, representing a +25.0% upside from the current price of $5.2. Price targets range from a low of $5.00 to a high of $8.00.
